相关实验视频

Updated: Jul 13, 2025

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence

Published on: December 23, 2022

通过导管关闭周膜心室隔膜缺陷,包括多窗和Gerbode类型缺陷,使用Lifetech Konar设备

Francois Godart¹, Jean Benoit Baudelet¹, Alexandre Delarue¹

¹Department of Pediatric Cardiology and Congenital Heart Disease, Institut Cœur Poumon, CHRU Lille, 59000 Lille, France.

Journal of clinical medicine

|October 14, 2023

概括

使用Lifetech Konar多功能封闭器 (MFO) 封闭周膜室隔膜缺陷 (PmVSD) 的跨导管封闭是安全有效的. 这项单一中心研究表明,成功关闭PMVSD,包括复杂的病例,并发症最小.

科学领域:

心脏病学心脏病学
干预心脏病学干预心脏病学
儿童心脏病学儿童心脏病学

背景情况:

过导管闭合是围膜腹腔隔膜缺陷 (PmVSD) 的新兴替代方案.
新的遮装置正在提高这种程序的有效性和安全性.
利夫泰克康纳多功能封闭器 (MFO) 是一种用于PMVSD封闭的新型设备.

研究的目的:

评估Lifetech Konar多功能封闭器 (MFO) 的安全性和有效性,用于跨导管PmVSD封闭.
在一个连续的患者队列中报告MFO植入的单一中心经验.
评估患有简单和复杂PmVSD的患者的结局,包括多和Gerbode类型缺陷.

主要方法:

从2019年3月到2022年10月,对43名连续接受PMVSD关闭的患者进行了回顾性分析.
患者在全身麻醉下接受了MFO装置,使用了逆行和前行两种方法.
记录了光镜时间,辐射剂量,手术成功率和并发症率. 心声检查评估了分流状态和门反.

主要成果:

在所有43名患者中成功植入MFO.
逆向方法与显著降低辐射剂量和更短的光镜时间 (p=0.042,p=0.002) 相联系.
平均11个月的随访后,77%的患者实现了完全闭塞,没有报告重大并发症. 在13个多孔缺陷中的7个缺陷中,没有残留的分流.

结论:

该Lifetech Konar多功能封闭器 (MFO) 证明了通过导管PmVSD关闭的安全性和有效性,包括复杂的多窗和Gerbode类型缺陷.
逆行方法在减少辐射暴露和光镜时间方面具有优势.
虽然初步结果是有希望的,但需要长期跟进,以充分确定MFO的PmVSD关闭安全概况.

关键词:

科纳尔-MFO设备的设备遗传性心脏病是一种先天性心脏病.儿科心脏病学儿科心脏病学周膜性VSD是什么意思

更多相关视频

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

相关概念视频

Mitral Stenosis III: Medical Management

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...

Mitral Stenosis I: Introduction

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...